Psychiatry and Mood Disorders
Clinical research activity includes treatment-focused studies in bipolar affective disorder, with interest in adjunctive approaches that support standard psychiatric care.
- Bipolar disorder
- Adjunctive therapy
- Psychiatric treatment response
The sponsor’s psychiatric portfolio is centered on improving symptom control and treatment outcomes in a major affective illness.
Neurology and Multiple Sclerosis
Research also extends to multiple sclerosis, with a specific focus on the secondary progressive form and its neurological burden.
- Secondary progressive multiple sclerosis
- Neurological disability
- Disease progression
This area reflects interest in therapies aimed at modifying progression in chronic demyelinating disease.
Neuroprotection and Brain Atrophy
One of the research themes involves preservation of brain volume in progressive neurological disease, highlighting concern for structural neurodegeneration.
- Brain volume loss
- Neurodegenerative change
- Structural MRI findings
The clinical interest lies in slowing tissue loss associated with worsening neurological function.
Inflammation and Immunomodulation
The sponsor’s studies include therapies with potential anti-inflammatory and immunomodulatory relevance across psychiatric and neurological disease settings.
- Inflammatory pathways
- Immune-mediated disease
- Therapeutic modulation
This domain connects treatment development in mood disorders and multiple sclerosis through shared biological mechanisms of interest.
